News & Information
At Memorial Sloan Kettering, our leading edge research is constantly advancing what we know about cancer and new discoveries are improving care for patients here, and all over the world. In News and Information, you will find information about our groundbreaking work and the dedicated professionals who make it all happen.
For Journalists
Connect with us to reach MSK experts for media inquiries, source story ideas and download MSK digital assets.
Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing.
"Get the Vaccine to Save Lives" aims to help Americans feel safe and confident about receiving a COVID-19 vaccine.
In the News
MSK ranked #17 out of 500 companies and is the second highest ranked hospital.
Read about why Jae Park joined his colleagues at MSK and New York-Presbyterian to publicly show a united stance against hate.
TV anchor Al Roker discusses his own prostate cancer experiences, disparities in cancer care and outcomes for people of color, the importance of cancer screening for Black men, and more with Dr. Carol Brown, a gynecological oncology surgeon at Memorial Sloan Kettering and Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering.
Stay Connected with MSK
News Releases
During a virtual awards ceremony, MSK and the Robbins Family Foundation recognized eight distinguished MSK staff members and one team for their exemplary service. Each member was honored with the 2021 Robbins Family Award for Nursing Excellence.
Since its inception at MSK 10 years ago, the Immigrant Health and Cancer Disparities (IHCD) Service has made significant progress in addressing barriers to access to cancer treatment and other healthcare for underserved communities across New York City and beyond.
In her new role, Dr. Hsu will work to diversify matriculating classes and train students to become skilled leaders as both clinicians and biomedical researchers.
Media Coverage
In a presentation at the 17th Annual Skin of Color Society Scientific Symposium, MSK’s Steven Wang outlined three current controversies and delved into the research behind them.
Wednesday, May 12, 2021
In a year dominated by the COVID-19 pandemic, the 2021 the National Comprehensive Cancer Network (NCCN) annual conference showcased a new initiative to reduce racial disparities in cancer care, educational presentations, updates on NCCN practice guidelines, interactive polling, and moderator-fielded question and answer sessions. MSK’s Fernanda Polubriaginof is quoted on MSK Engage, which enables the collection of patient-generated health data.
Wednesday, May 12, 2021
A radiation dose that is less than half of the standard treatment is a promising option for some patients with HPV-positive throat cancer, according to findings from a recent study. MSK’s Nancy Lee is featured.
Wednesday, May 12, 2021
News from the Lab
The DNA breaks that occur during meiosis are necessary but dangerous. Scientists now have a better handle on how cells control the chaos.
Meet molecular biologist Agnel Sfeir, who joined SKI's Molecular Biology Program in March 2021.
The [email protected] fellowship will provide Dr. Delconte with two years of financial support for her research on natural killer cells in cancer.
MSK News
Scientists at Memorial Sloan Kettering are learning how to turn cancer’s appetite against itself.
Learn about Verdun Perry’s devotion to fund rare cancer research at MSK.
The MSK Immigrant Health & Cancer Disparities service improves people’s lives in communities that too often get overlooked and suffer disproportionately from cancer, including lack of access to care.
2019 Annual Report: It Starts with One
A unique program at MSK Kids is dedicated to finding a cure for every child with cancer.
Researchers in the Sloan Kettering Institute conducted a far-reaching analysis of single cells that is changing how we think about development.
Liquid biopsies are shedding light on cancer DNA that’s hiding out in the bloodstream. MSK-ACCESS is one such test that took a big leap forward in 2019.